TY - JOUR T1 - Recommendations for the Management of Comorbidity in Patients With Axial Spondyloarthritis in Clinical Practice JO - Reumatología Clínica (English Edition) T2 - AU - González,Carlos AU - Curbelo Rodríguez,Rafael AU - Torre-Alonso,Juan Carlos AU - Collantes,Eduardo AU - Castañeda,Santos AU - Hernández,M. Victoria AU - Urruticoechea-Arana,Ana AU - Nieto-González,Juan Carlos AU - García,Javier AU - Abad,Miguel Ángel AU - Ramírez,Julio AU - Suárez,Carmen AU - Dalmau,Regina AU - Martín-Arranz,Maria Dolores AU - León,Leticia AU - Hermosa,Juan Carlos AU - Obaya,Juan Carlos AU - Otón,Teresa AU - Carmona,Loreto SN - 21735743 M3 - 10.1016/j.reumae.2017.03.006 DO - 10.1016/j.reumae.2017.03.006 UR - https://www.reumatologiaclinica.org/en-recommendations-for-management-comorbidity-in-articulo-S2173574318300832 AB - ObjectivesTo identify priorities among comorbidities in axial spondyloarthritis (AxSpA) and recommend how to follow them from an eminently practical perspective. MethodsA multidisciplinary group was selected (10 rheumatologists—6 of them experts in AxSpA—, 2 general practitioners, an internist, a cardiologist, a gastroenterologist and a psychologist). In a first discussion meeting, the scope and users were established and a list of comorbidities was voted based on frequency and impact. The panellists had to defend the inclusion of each comorbidity/item in the document with consistent arguments. Four panellists and two methodologists developed systematic reviews on controversial topics. In a second meeting, the results of the reviews and the arguments concerning the items to be included were presented. After the meeting, the final document was drafted. ResultsThe final document includes two checklists, one for health professionals and another for patients; they incorporate cardiovascular risk, renal comorbidities, gastrointestinal risk, lifestyle, risk of infections and vaccinations, pulmonary involvement, concomitant medication, psycho-affective disorders, osteoporosis, and risk of fracture. In addition, the document reflects the arguments favouring the inclusion of each item and how to record the items for subsequent collection. The panel considered it also appropriate to likewise establish «practices to avoid» applicable to comorbidity in AxSpA. ConclusionsTwo checklists and a list of situations to avoid were generated to facilitate the management of comorbidities in AxSpA. In a future step, their utility and acceptance will be tested by a broad group of users that includes doctors, patients and nurses. ER -